Sagar Sardesai - Research output - The Ohio State University

View Scopus Profile

h-index

Research activity per year

54 Article
7 Review article
2 Comment/debate

2 results

Filter

2025
Correction to: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)
Coombes, R. C., Howell, S., Lord, S. R., Kenny, L., Mansi, J., Mitri, Z., Palmieri, C., Chap, L. I., Richards, P., Gradishar, W., Sardesai, S., Melear, J., O’Shaughnessy, J., Ward, P., Chalasani, P., Arkenau, T., Baird, R. D., Jeselsohn, R., Ali, S. & Clack, G. & 3 others, Bahl, A., McIntosh, S. & Krebs, M. G., Dec 2025, In: Nature Communications. 16, 1, 2242.
Research output: Contribution to journal › Comment/debate

Open Access
2023
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)
Coombes, R. C., Howell, S., Lord, S. R., Kenny, L., Mansi, J., Mitri, Z., Palmieri, C., Chap, L. I., Richards, P., Gradishar, W., Sardesai, S., Melear, J., O’Shaughnessy, J., Ward, P., Chalasani, P., Arkenau, T., Baird, R. D., Jeselsohn, R., Ali, S. & Clack, G. & 3 others, Bahl, A., McIntosh, S. & Krebs, M. G., Dec 2023, In: Nature Communications. 14, 1, 4741.
Research output: Contribution to journal › Comment/debate

Open Access
1 Scopus citations